Stocks Comparison
Altisource Portfolio Solutions vs Oriental Culture: revenue, profit, margins and growth compared
Altisource Portfolio Solutions brought in $171M of revenue in fiscal 2025, Oriental Culture $1.9M in fiscal 2025. Revenue changed by +6.8% at Altisource Portfolio Solutions and +203.3% at Oriental Culture on the year before, so Oriental Culture grew faster. Altisource Portfolio Solutions kept 0.9% of its revenue as net profit, Oriental Culture -204.2%.
Side by side, latest fiscal year
| ASPS | OCG | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $171M | $1.9M |
| Revenue growth | +6.8% | +203.3% |
| Net income | $1.6M | -$3.9M |
| Net margin | 0.9% | -204.2% |
| Free cash flow | -$5.1M | n/a |
| Free cash flow margin | -3.0% | n/a |
| Earnings per share (diluted) | $0.15 | -$107.26 |
| Cash | $26.6M | $32.3M |
| Debt | $191.1M | n/a |
| Price to earnings | 36.6 | n/a |
| Market value | $62.7M | $2.9M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #683 of 955 · Consumer discretionary | #932 of 955 · Consumer discretionary |
Over the years
Questions about Altisource Portfolio Solutions and Oriental Culture
Which is bigger by revenue, Altisource Portfolio Solutions or Oriental Culture?
Altisource Portfolio Solutions is bigger by revenue: $171M in fiscal 2025, against $1.9M for Oriental Culture in fiscal 2025.
Which keeps more of its revenue as profit, Altisource Portfolio Solutions or Oriental Culture?
Altisource Portfolio Solutions had a net margin of 0.9% in fiscal 2025; Oriental Culture had -204.2% in fiscal 2025.
Which grew revenue faster, Altisource Portfolio Solutions or Oriental Culture?
In their latest fiscal years revenue changed by +6.8% at Altisource Portfolio Solutions and +203.3% at Oriental Culture.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.